Dimensional Fund Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $56.8M | Sell |
|
|||||
|
2025
Q2 | $44.6M | Sell |
|
|||||
|
2025
Q1 | $31.9M | Sell |
|
|||||
|
2024
Q4 | $37.3M | Buy |
|
|||||
|
2024
Q3 | $38.7M | Sell |
|
|||||
|
2024
Q2 | $51.3M | Buy |
|
|||||
|
2024
Q1 | $63.5M | Buy |
|
|||||
|
2023
Q4 | $48.8M | Sell |
|
|||||
|
2023
Q3 | $39.9M | Buy |
|
|||||
|
2023
Q2 | $39.9M | Sell |
|
|||||
|
2023
Q1 | $34.4M | Sell |
|
|||||
|
2022
Q4 | $31.5K | Buy |
|
|||||
|
2022
Q3 | $42.4M | Buy |
|
|||||
|
2022
Q2 | $26.7M | Buy |
|
|||||
|
2022
Q1 | $15.1M | Sell |
|
|||||
|
2021
Q4 | $19.6M | Buy |
|
|||||
|
2021
Q3 | $17.3M | Buy |
|
|||||
|
2021
Q2 | $23.6M | Buy |
|
|||||
|
2021
Q1 | $16.9M | Buy |
|
|||||
|
2020
Q4 | $16.5M | Buy |
|
|||||
|
2020
Q3 | $8.51M | Buy |
|
|||||
|
2020
Q2 | $7.42M | Buy |
|
|||||
|
2020
Q1 | $3.75M | Buy |
|
|||||
|
2019
Q4 | $2.83M | Buy |
|